Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Russell

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Clinical Pharmacology|April 6, 2019
Drugs for the treatment of metabolic bone diseasesMatthew T Drake, Serge Cremers, R Graham Russell, et al.
Calcified Tissue International|April 5, 2007
Serum from postmenopausal women directs differentiation of human clonal osteoprogenitor cells from an osteoblastic toward an adipocytic phenotypeBradley Stringer, Rachel Waddington, Adam Houghton, et al.
Tissue Engineering|May 24, 2007
Bespoke human hypertrophic chondrocytic cell lines provide the osteoinductive signals required for vascularized bone formationBradley Stringer, Rachel Waddington, Alastair Sloan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 6, 2018
Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell TypesNeus Roca-Ayats, Pei Ying Ng, Natàlia Garcia-Giralt, et al.
The New England Journal of Medicine|May 4, 2017
GGPS1 Mutation and Atypical Femoral Fractures with BisphosphonatesNeus Roca-Ayats, Susana Balcells, Natàlia Garcia-Giralt, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Clinical Pharmacology|April 6, 2019
Drugs for the treatment of metabolic bone diseasesMatthew T Drake, Serge Cremers, R Graham Russell, et al.
Calcified Tissue International|April 5, 2007
Serum from postmenopausal women directs differentiation of human clonal osteoprogenitor cells from an osteoblastic toward an adipocytic phenotypeBradley Stringer, Rachel Waddington, Adam Houghton, et al.
Tissue Engineering|May 24, 2007
Bespoke human hypertrophic chondrocytic cell lines provide the osteoinductive signals required for vascularized bone formationBradley Stringer, Rachel Waddington, Alastair Sloan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 6, 2018
Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell TypesNeus Roca-Ayats, Pei Ying Ng, Natàlia Garcia-Giralt, et al.
The New England Journal of Medicine|May 4, 2017
GGPS1 Mutation and Atypical Femoral Fractures with BisphosphonatesNeus Roca-Ayats, Susana Balcells, Natàlia Garcia-Giralt, et al.
Pageof 2